(Q75235129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Ruediger E Port

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Daniela Kiepe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Michael Van Guilder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Roger W Jelliffe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Otto Mehls

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

57-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14715051%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-200443010-00004

17 November 2019

exact match

0 references

cites work

In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.

1 reference

12 December 2020

Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics

1 reference

12 December 2020

Erythropoietin in the neonate

1 reference

12 December 2020

Drug delivery optimization through Bayesian networks: an application to erythropoietin therapy in uremic anemia.

1 reference

12 December 2020

Nonerythropoietic roles of erythropoietin in the fetus and neonate

1 reference

12 December 2020

Effect of recombinant human erythropoietin treatment on renal anemia and body growth of children with end-stage renal disease. The European Multicenter Study Group

1 reference

12 December 2020

A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.

1 reference

12 December 2020

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1 reference

12 December 2020

Erythropoietin treatment in children with renal failure

1 reference

12 December 2020

Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients

1 reference

12 December 2020

A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination

1 reference

12 December 2020

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000

1 reference

12 December 2020

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure.

1 reference

12 December 2020

Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects.

1 reference

12 December 2020

Some suggestions for measuring predictive performance

1 reference

12 December 2020

Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep.

1 reference

12 December 2020

[Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex). Results of a French multicenter clinical trial]

1 reference

12 December 2020

A pharmacodynamic model of erythropoietin therapy for uremic anemia

1 reference

12 December 2020

European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure

1 reference

12 December 2020

Predicting the time course of haemoglobin in children treated with erythropoietin for renal anaemia

1 reference

12 December 2020

Population Pharmacokinetics/Dynamics*

1 reference

12 December 2020

Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.

1 reference

12 December 2020

A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans.

1 reference

12 December 2020

Red blood cell survival studies

1 reference

12 December 2020

Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients

1 reference

12 December 2020